FDA applicant
Micro Therapeutics, Inc. d/b/a ev3 Neurovascular
FDA records 33 decisions for Micro Therapeutics, Inc. d/b/a ev3 Neurovascular (Irvine, CA) from 2011 to 2025: 32 510(k) clearances and 1 original PMA approval. Most are in product codes NRY (Catheter, Thrombus Retriever) and POL (Neurovascular Mechanical Thrombectomy Device…). Since 2016 its 510(k)s took a median of 103 days from receipt to decision, against 110 for FDA’s reviews in the same codes and years. Its devices cite 54 predicates, 27 of them its own earlier devices. 14 recalls are linked to its devices, 11 Class I.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Micro Therapeutics, Inc. d/b/a ev3 Neurovascular’s devices, and how often a recall has named them.
FDA decisions per year
1in 2025
2026 so far, outlined.
Recalls per year
2in 2025
Class I Class II/III not classified
Planning a device like Micro Therapeutics, Inc. d/b/a ev3…’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report